Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid–sensing G protein–coupled receptors (GPCRs), sometimes called free fatty acid receptors (FFARs) or lipid-sensing GPCRs, are a subgroup of cell-surface receptors that detect extracellular free fatty acids and initiate intracellular signaling responses[1][2][4]. This family includes several distinct GPCRs—most notably GPR40 (FFAR1), GPR41 (FFAR3), GPR43 (FFAR2), GPR84, GPR119, and GPR120 (FFAR4)—which differ in fatty acid chain-length specificity, tissue localization, and biological roles[1][2]. These receptors regulate immune responses, metabolic signaling, and inflammation[1][2][3][4]. Dysregulation or targeting of these receptors is implicated in obesity, type 2 diabetes, atherosclerosis, and inflammatory diseases[1][3][4]. Each molecular subtype is studied individually as a potential therapeutic target, especially for metabolic diseases, but "fatty acid–sensing GPCR" as a class is a descriptive group rather than a single drug target.
Ligand (fatty acid)-induced activation of intracellular signaling pathways, notably via G proteins such as Gq/11[3]. Modulation of PI3K/Akt pathway leading to glucose uptake[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid–sensing G protein–coupled receptor.